Related Experiment Video
Updated: Jun 22, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Patient-specific classifications of human malignant disease
David R Parkinson1, Alessandra Cesano
1Nodality Inc, South San Francisco, CA 94080, USA. david.parkinson@nodality.com
Current Opinion in Molecular Therapeutics
|May 30, 2009
Summary
Current cancer classifications need updating due to targeted therapies. Personalized cancer biology characterization is essential for improved diagnosis, treatment selection, and efficient drug development.
Area of Science:
- Oncology
- Cancer Biology
- Translational Research
Background:
- Systematic classification of malignant disease is crucial for cancer diagnosis and treatment.
- Existing classifications are becoming inadequate with advances in biologically targeted anticancer agents.
- There is a growing need for patient-specific biological characterization in cancer care.
Purpose of the Study:
- To review recent efforts in characterizing tumor biology using new technologies.
- To discuss the integration of biological data into clinical oncology practice.
- To highlight the importance of revising cancer classification systems.
Main Methods:
- Review of recent technological advancements in tumor biology characterization.
- Analysis of data integrating tumor biology with clinical oncology.
- Exploration of methods for comprehensive patient-specific tumor data analysis.
Main Results:
- Significant biological diversity exists within traditional histological classification groups.
- Current classification systems show increasing inadequacies for targeted therapies.
- New methods can more comprehensively analyze individual patient tumor biology data.
Conclusions:
- Cancer classification systems require revision to incorporate biological insights.
- Patient-specific biological characterization is key for effective cancer treatment.
- Enhanced data analysis can improve the efficiency of anticancer therapeutic development.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...